Cargando…

Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome

Background: Intravenous injection of oral opioid substitution drugs (OSD) is widespread among injecting drug users. Several OSDs contain the polymer polyvinylpyrrolidone (PVP) as an excipient. Parenterally administered PVP of high molecular weight may accumulate in tissues and organs. This phenomeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Stalund, Ida Viken, Riise, Gro Nygard, Leh, Friedemann, Bjånes, Tormod Karlsen, Riise, Lars, Svarstad, Einar, Leh, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276182/
https://www.ncbi.nlm.nih.gov/pubmed/34316359
http://dx.doi.org/10.12688/f1000research.51927.2
_version_ 1783721855481282560
author Stalund, Ida Viken
Riise, Gro Nygard
Leh, Friedemann
Bjånes, Tormod Karlsen
Riise, Lars
Svarstad, Einar
Leh, Sabine
author_facet Stalund, Ida Viken
Riise, Gro Nygard
Leh, Friedemann
Bjånes, Tormod Karlsen
Riise, Lars
Svarstad, Einar
Leh, Sabine
author_sort Stalund, Ida Viken
collection PubMed
description Background: Intravenous injection of oral opioid substitution drugs (OSD) is widespread among injecting drug users. Several OSDs contain the polymer polyvinylpyrrolidone (PVP) as an excipient. Parenterally administered PVP of high molecular weight may accumulate in tissues and organs. This phenomenon was first described in the 1950s, when PVP was utilised in medication for parenteral use. We report a case of an opioid-addicted patient with extensive PVP–deposition caused by repeated injections of OSDs. Case presentation: A 30-year-old male drug addicted patient in opioid substitution therapy (OST) was repeatedly referred to his local hospital in a poor general condition. Work-up revealed severe normocytic anaemia, renal insufficiency, pancreas insufficiency and pathological fractures. Biopsies from fractured bones, bone marrow and gastric mucosa showed extensive infiltrates of histiocytes with intracytoplasmic vacuoles. Vacuole content stained slightly bluish in hematoxylin and eosin stain, red in Congo red stain and black in periodic acid methenamine silver stain. The morphological appearance and staining properties were in accordance with the diagnosis of PVP deposition. The patient had been injecting both buprenorphine tablets and a specific methadone syrup for several years. The methadone syrup contained large amounts of high molecular weight PVP, making it the most likely cause of the deposition. His health quickly deteriorated and he died, impaired by multi-organ failure and cachexia, five years after the first diagnosis of PVP-deposition. The autopsy revealed extensive PVP-deposition in all sampled organs and tissues. Conclusions: Histological investigation and the correct identification of PVP in the biopsies led to the discovery of a severe adverse effect from long-standing misuse of a drug. The disseminated PVP deposition likely contributed to multi-organ dysfunction and cachexia with a fatal outcome. The deposited PVP likely originated from repeated injections of a certain methadone syrup.
format Online
Article
Text
id pubmed-8276182
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-82761822021-07-26 Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome Stalund, Ida Viken Riise, Gro Nygard Leh, Friedemann Bjånes, Tormod Karlsen Riise, Lars Svarstad, Einar Leh, Sabine F1000Res Case Report Background: Intravenous injection of oral opioid substitution drugs (OSD) is widespread among injecting drug users. Several OSDs contain the polymer polyvinylpyrrolidone (PVP) as an excipient. Parenterally administered PVP of high molecular weight may accumulate in tissues and organs. This phenomenon was first described in the 1950s, when PVP was utilised in medication for parenteral use. We report a case of an opioid-addicted patient with extensive PVP–deposition caused by repeated injections of OSDs. Case presentation: A 30-year-old male drug addicted patient in opioid substitution therapy (OST) was repeatedly referred to his local hospital in a poor general condition. Work-up revealed severe normocytic anaemia, renal insufficiency, pancreas insufficiency and pathological fractures. Biopsies from fractured bones, bone marrow and gastric mucosa showed extensive infiltrates of histiocytes with intracytoplasmic vacuoles. Vacuole content stained slightly bluish in hematoxylin and eosin stain, red in Congo red stain and black in periodic acid methenamine silver stain. The morphological appearance and staining properties were in accordance with the diagnosis of PVP deposition. The patient had been injecting both buprenorphine tablets and a specific methadone syrup for several years. The methadone syrup contained large amounts of high molecular weight PVP, making it the most likely cause of the deposition. His health quickly deteriorated and he died, impaired by multi-organ failure and cachexia, five years after the first diagnosis of PVP-deposition. The autopsy revealed extensive PVP-deposition in all sampled organs and tissues. Conclusions: Histological investigation and the correct identification of PVP in the biopsies led to the discovery of a severe adverse effect from long-standing misuse of a drug. The disseminated PVP deposition likely contributed to multi-organ dysfunction and cachexia with a fatal outcome. The deposited PVP likely originated from repeated injections of a certain methadone syrup. F1000 Research Limited 2021-07-07 /pmc/articles/PMC8276182/ /pubmed/34316359 http://dx.doi.org/10.12688/f1000research.51927.2 Text en Copyright: © 2021 Stalund IV et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Stalund, Ida Viken
Riise, Gro Nygard
Leh, Friedemann
Bjånes, Tormod Karlsen
Riise, Lars
Svarstad, Einar
Leh, Sabine
Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title_full Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title_fullStr Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title_full_unstemmed Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title_short Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
title_sort case report: polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276182/
https://www.ncbi.nlm.nih.gov/pubmed/34316359
http://dx.doi.org/10.12688/f1000research.51927.2
work_keys_str_mv AT stalundidaviken casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT riisegronygard casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT lehfriedemann casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT bjanestormodkarlsen casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT riiselars casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT svarstadeinar casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome
AT lehsabine casereportpolyvinylpyrrolidonedepositiondiseasefromrepeatedinjectionofopioidsubstitutiondrugsreportofacasewithafataloutcome